Trazimera, Herceptin Biosimilar, Gains FDA Approval
Indicated for breast cancer, and gastric or gastroesophageal junction adenocarcinoma.
Lower-Priced Insulin Coming Soon
Eli Lilly creates generic Humalog priced 50% lower
AllianceRx Walgreens Prime to Distribute Probuphine Implants
Restricted implants indicated for maintenance of opioid dependency.
New Drug Review: Dsuvia (Sufentanil) for Acute Refractory Pain
Sublingual form approved for short-term use.
Medtronic plc Granted Breakthrough Device Clearance for PCL Insulin Pump
The new device will increase real-time personalization and predictive diagnostics for patients.
EGATEN for Treatment of Fascioliasis
Anthelmintic tablet for patients 6 years of age and older.
Cablivi for Acquired Thrombotic Thrombocytopenic purpura
What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.
Jeuveau (PrabotulinumtoxinA-xvfs) for Glabellar Lines
What you need to know about the new botulinum toxin product.
Generic Tolterodine Tartrate ER Capsules for Overactive Bladder
Ultomiris for Paroxysmal Nocturnal Hemoglobinuria
Elzonris for Blastic Plasmacytoid Dendritic Cell Neoplasm
Siklos for Recurrent Sickle Cell Anemia Pain
Xospata for Relapsed or Refractory AML
Firdapse for LEMS in Adults
Vitrakvi for Adult and Pediatric Solid Tumors
Gamifant for Primary Hemophagocytic Lymphohistiocytosis
Daurismo for Newly Diagnosed AML
Aemcolo for Noninvasive Escheria coli Infection
Yupelri for Chronic Obstructive Pulmonary Disease
Xofluza for Acute Uncomplicated Influenza
Talzenna for gBRCAm HER2-negative Locally Advanced or Metastatic Breast Cancer
Tegsedi for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
Revcovi for Adenosine Deaminase Severe Combined Immune Deficiency
Nuzrya for CAPB or ABSSI
Tecentriq for Locally Advanced or Metastatic Urothelial Carcinoma
Generic Albenza Pills Now Available for Tapeworm, Parasite Infections
Duvelisib for Relapsed or Refractory CLL/SLL
The 10 Most Exciting Drugs in the 2019 Pipeline
Approved and upcoming drugs to look forward to this year.
Dacomitinib Approved for Non-Small Cell Lung Cancer
Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.
The Smart Technology That Will Change Diabetes Care
GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management.
